Conference Coverage
Conference Coverage
Patients on methotrexate show T-cell response to Pfizer vaccine
Despite poor antibody response to the mRNA COVID-19 vaccine, cellular immunity was generated in patients taking methotrexate, new research shows...
Conference Coverage
The pandemic hurt patients with liver disease in many ways
Conference Coverage
‘Staggering’ doubling of type 2 diabetes in children during pandemic
Two new studies show a shocking increase in type 2 diabetes among U.S. children during the pandemic, with increased severity at presentation....
Conference Coverage
Unmanaged diabetes, high blood glucose tied to COVID-19 severity
Findings suggest in part that hospitalized COVID-19 patients need aggressive treatment of hyperglycemia, regardless of the diagnosis of diabetes...
Conference Coverage
Guidance provided for telepsychiatry in tardive dyskinesia
An in-person visit is preferred for initial evaluation and diagnosis of TD, Dr. Rif S. El-Mallakh reported.
Conference Coverage
COVID-19 vaccines are safe and effective for patients with migraine
The only real clinical concern clinicians may need to consider is the headache differential for women under age 60 who call with a headache a week...
Latest News
Trial offers first look at how tralokinumab-treated patients weather COVID-19
The average duration of COVID-19 infection was 15 days and severity of disease was mild in 35 patients (69%), moderate in 14 (27%), and severe in...
Conference Coverage
Migraine linked to more COVID-19 infections, symptoms but less health care utilization
People with migraine are either more susceptible to contracting COVID-19, or they may be more sensitive to the development of symptoms once COVID-...
Conference Coverage
Mavrilimumab may aid severe COVID-19 recovery
The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 versus...
Conference Coverage
Free U.K. tool could help guide COVID-19 care for cancer patients